Publication | Open Access

Lisocabtagene maraleucel in chronic lymphocytic leukaemia and small lymphocytic lymphoma (TRANSCEND CLL 004): a multicentre, open-label, single-arm, phase 1–2 study

Hematological MalignancyLymphoid NeoplasiaTranscend Cll 004MedicineHematologyPathologySmall Lymphocytic LymphomaLisocabtagene MaraleucelOncologyRadiation OncologyCancer ResearchHealth Sciences